Literature DB >> 6630108

Transferable trimethoprim resistance in three Finnish hospitals.

P Huovinen, L Pulkkinen, P Toivanen.   

Abstract

Resistance to trimethoprim in urinary tract isolates was studied in the Turku City Hospital in 1979 and 1980-81 and in the Turku and Kuopio University Central Hospitals in 1980-81. In the Turku City Hospital no changes occurred during this time in the frequency of strains highly-resistant to trimethoprim (MIC greater than 1000 mg/l) or of those in which transferable resistance was demonstrated. However, the nature of resistance has changed since 1979, when the only transferable pattern was trimethoprim-ampicillin resistance. In 1980-81 over half of the transfer-positive stains transferred only trimethoprim resistance. In the university hospitals the strains highly-resistant to trimethoprim occurred in 36.8% of strains resistant to greater than or equal to 8 mg/l. This is significantly less than 68.7% observed at the same time in the Turku City Hospital. Among the highly-resistant strains the frequency of those transferring resistance was the same in the university hospitals as in the Turku City Hospital.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6630108     DOI: 10.1093/jac/12.3.249

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  Emergence of trimethoprim resistance in relation to drug consumption in a Finnish hospital from 1971 through 1984.

Authors:  P Huovinen; L Pulkkinen; H L Helin; M Mäkilä; P Toivanen
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

2.  Characterization of trimethoprim resistance by use of probes specific for transposon Tn7.

Authors:  L Pulkkinen; P Huovinen; E Vuorio; P Toivanen
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

3.  The distribution of the DHFR genes in trimethoprim-resistant urinary tract isolates from Taiwan.

Authors:  L L Chang; S F Chang; T Y Chow; W J Wu; J C Chang
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.